Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schattenberg
L Stump

Showing results (71-80 of 392) with videos related to

Pageof 40
Sort By:
Journal of Cardiovascular Pharmacology|October 1, 1990
Cardiac electrophysiologic effects of McN-5691, a new calcium-channel blocking antihypertensive agentB P Damiano, S F Flaim, A Gill, et al.
Medical Sciences (Basel, Switzerland)|September 22, 2022
Elucidating the Role of <i>Chmp1</i> Overexpression in the Transport of Polyamines in <i>Drosophila melanogaster</i>Coryn L Stump, Robert A Casero, Otto Phanstiel, et al.
Amino Acids|April 12, 2019
Knocking down raptor in human keratinocytes affects ornithine decarboxylase in a post-transcriptional Manner following ultraviolet B exposureCoryn L Stump, Robert P Feehan, Torey Jordan, et al.
Biomolecules|July 29, 2023
Yeast Models of Amyotrophic Lateral Sclerosis Type 8 Mimic Phenotypes Seen in Mammalian Cells Expressing Mutant VAPB<sup>P56S</sup>AnnaMari L Stump, Daniel J Rioux, Richard Albright, et al.
Cancers|February 13, 2025
Curcumin and Its Derivatives in Hepatology: Therapeutic Potential and Advances in Nanoparticle FormulationsErsin Karatayli, Shifana C Sadiq, Jörn M Schattenberg, et al.
Basic Research in Cardiology|July 6, 2000
Arrhythmogenic potential of positive inotropic agentsG L Stump, A A Wallace, D B Gilberto, et al.
European Journal of Internal Medicine|February 14, 2025
Risk of hepatic decompensation or HCC is similar in patients with ALD- and MASLD-cirrhosis: A population-based cohort studyJoost Boeckmans, Linnea Widman, Ying Shang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 31, 2023
PNPLA3 I148M and response to treatment for hepatic steatosis: A systematic reviewJoost Boeckmans, Alexandra Gatzios, Jörn M Schattenberg, et al.
The Lancet Regional Health. Europe|December 17, 2024
Clinical utility of the Fibrosis-4 index for predicting mortality in patients with heart failure with or without metabolic dysfunction-associated steatotic liver disease: a prospective cohort studyJoost Boeckmans, Jürgen H Prochaska, Alexander Gieswinkel, et al.
International Immunopharmacology|December 20, 2011
Novel, orally active, proteasome inhibitor, delanzomib (CEP-18770), ameliorates disease symptoms and glomerulonephritis in two preclinical mouse models of SLEMatthew M Seavey, Lily D Lu, Kristine L Stump, et al.
Pageof 40

Showing results (71-80 of 392) with videos related to

Sort By:
Pageof 40
Journal of Cardiovascular Pharmacology|October 1, 1990
Cardiac electrophysiologic effects of McN-5691, a new calcium-channel blocking antihypertensive agentB P Damiano, S F Flaim, A Gill, et al.
Medical Sciences (Basel, Switzerland)|September 22, 2022
Elucidating the Role of <i>Chmp1</i> Overexpression in the Transport of Polyamines in <i>Drosophila melanogaster</i>Coryn L Stump, Robert A Casero, Otto Phanstiel, et al.
Amino Acids|April 12, 2019
Knocking down raptor in human keratinocytes affects ornithine decarboxylase in a post-transcriptional Manner following ultraviolet B exposureCoryn L Stump, Robert P Feehan, Torey Jordan, et al.
Biomolecules|July 29, 2023
Yeast Models of Amyotrophic Lateral Sclerosis Type 8 Mimic Phenotypes Seen in Mammalian Cells Expressing Mutant VAPB<sup>P56S</sup>AnnaMari L Stump, Daniel J Rioux, Richard Albright, et al.
Cancers|February 13, 2025
Curcumin and Its Derivatives in Hepatology: Therapeutic Potential and Advances in Nanoparticle FormulationsErsin Karatayli, Shifana C Sadiq, Jörn M Schattenberg, et al.
Basic Research in Cardiology|July 6, 2000
Arrhythmogenic potential of positive inotropic agentsG L Stump, A A Wallace, D B Gilberto, et al.
European Journal of Internal Medicine|February 14, 2025
Risk of hepatic decompensation or HCC is similar in patients with ALD- and MASLD-cirrhosis: A population-based cohort studyJoost Boeckmans, Linnea Widman, Ying Shang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 31, 2023
PNPLA3 I148M and response to treatment for hepatic steatosis: A systematic reviewJoost Boeckmans, Alexandra Gatzios, Jörn M Schattenberg, et al.
The Lancet Regional Health. Europe|December 17, 2024
Clinical utility of the Fibrosis-4 index for predicting mortality in patients with heart failure with or without metabolic dysfunction-associated steatotic liver disease: a prospective cohort studyJoost Boeckmans, Jürgen H Prochaska, Alexander Gieswinkel, et al.
International Immunopharmacology|December 20, 2011
Novel, orally active, proteasome inhibitor, delanzomib (CEP-18770), ameliorates disease symptoms and glomerulonephritis in two preclinical mouse models of SLEMatthew M Seavey, Lily D Lu, Kristine L Stump, et al.
Pageof 40